This study investigates gastrointestinal cancer. It focuses on improving the quality of care for Black patients diagnosed with this condition.
The study evaluates the effectiveness of biomarker testing and evidence-based care. It also explores the impact of health literacy and clinical trial enrollment assistance on patient outcomes.
- Who can participate: Adults aged 18 and older who are newly diagnosed Black patients with gastrointestinal cancer are eligible. Participants must be able to understand and consent to the study procedures.
- Study details: Participants will receive standard-of-care treatment. The study includes assistance with clinical trial enrollment and education on their condition. A placebo, an inactive substance, will not be used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand